MS-DRG 725 – Benign Prostatic Hypertrophy with MCC
A Medical DRG in MDC 12 (Diseases & Disorders of the Male Reproductive System). Inpatient cases group to DRG 725 when the ICD-10-CM principal diagnosis is one of the 5 codes listed below and a secondary diagnosis on the major complication or comorbidity (MCC) list is present. Its FY 2026 relative weight is 1.1702 with a geometric mean length of stay of 3.8 days.
Severity family
The grouper first assigns the case to MDC 12 from the principal diagnosis and finds no qualifying operating-room procedure (this is a Medical DRG; ICD-10-PCS codes do not drive assignment here), then applies the severity split from secondary diagnoses: with MCC → 725; without MCC → 726.
Principal Diagnosis Codes 5 codes · 2 categories
N40 Benign prostatic hyperplasia4 codes
N42 Other and unspecified disorders of prostate1 code
- N42.83 Cyst of prostate
Procedure Codes
Frequently Asked Questions
What is MS-DRG 725?
MS-DRG 725 (Benign Prostatic Hypertrophy with MCC) is a medical DRG in MDC 12 (Diseases & Disorders of the Male Reproductive System). Its FY 2026 relative weight is 1.1702 with a geometric mean length of stay of 3.8 days.
What is the difference between DRG 725, 726?
All 2 share the same base category; the severity of secondary diagnoses separates them: 725 (with MCC), 726 (without MCC). A major complication or comorbidity (MCC) places the case in the highest-weighted DRG of the family; a CC in the middle; neither in the lowest.
How many diagnosis codes group to DRG 725?
5 ICD-10-CM principal diagnosis codes group to this DRG, spanning 2 three-character categories.
What is the relative weight of DRG 725?
The FY 2026 relative weight of this DRG is 1.1702, meaning reimbursement of roughly 1.17 times the average Medicare inpatient case. Multiply by a hospital's blended base rate for the approximate payment.
